Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Respiratory tract diseases

US authorities investigate 150 cases of respiratory illness linked to e-cigarette use

The US Centers for Disease Control and Prevention (CDC) is investigating nearly 150 cases of respiratory illness, primarily in teenagers and young people, that are potentially linked to e-cigarette use.

Some 15 US states have reported a total of 149 people attending hospital between 28 June 2019 and 20 August 2019 with symptoms including breathing difficulty, shortness of breath and chest pain after using e-cigarettes in the weeks and months before.

The CDC said the cases are primarily teenagers and young adults. However, some states have also confirmed cases involving older patients.

In a statement published on 21 August 2019, the CDC said that it had “not identified a cause, but all reported cases have e-cigarette product use or ‘vaping’”, adding that “many cases” also included the recent use of tetrahydrocannabinol-containing products.

“However, no specific product has been identified in all cases, nor has any product been conclusively linked to illnesses,” it said.

“The state departments of health are investigating the possible cause of the illness by testing patient specimens and e-cigarette products.”

Ngozi Ezike, director of the Illinois Department of Public Health, which reported six confirmed cases as of 8 August 2019, said: “Vaping among teens has increased dramatically over the last several years.

“While the short- and long-term effects of vaping are still being researched, these recent hospitalisations heighten the need for parents talk with their teens about vaping, and for both to understand the consequences and potential dangers of vaping.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206988

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.